These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 929008)

  • 1. [Fibrinolysis in systemic lupus erythematosus. Analysis of 50 personal cases (preliminary communication)].
    Wysocka K; Kiczak J
    Reumatologia; 1977; 15(3):345-50. PubMed ID: 929008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemorrhagic diathesis caused by platelet function disorders in systemic lupus erythematosus].
    Kreps Z; Czestochowska E
    Pol Tyg Lek; 1979 Feb; 34(8):303-4. PubMed ID: 441044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunocoagulopathy (lupus anticoagulant) with severe hemorrhagic diathesis in systemic lupus erythematosus].
    Wysocka K; Kiczak J; Pozorska D
    Wiad Lek; 1977 Jul; 30(14):1129-34. PubMed ID: 888437
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma coagulation and fibrinolysis in systemic lupus erythematosus (author's transl)].
    Arnalich Fernández F; Gil Aguado A; Enríquez L; Navarro JL; Barbado Hernández FJ; Vázquez Rodríguez JJ
    Med Clin (Barc); 1979 Jun; 73(1):5-10. PubMed ID: 470505
    [No Abstract]   [Full Text] [Related]  

  • 5. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.
    Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI
    J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study of serum interferon in systemic lupus erythematosus and its significance.
    Shi SY; Feng SF; Wen YM; He LF; Huang YX
    Chin Med J (Engl); 1986 Mar; 99(3):229-34. PubMed ID: 3095051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Status of fibrinolysis in systemic lupus erythematosus].
    Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):184-90. PubMed ID: 2427400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symptomatic thrombopenias. Difficulties of early diagnosis and therapeutic possibilities].
    Clément F
    Schweiz Med Wochenschr; 1966 Sep; 96(37):1209-11. PubMed ID: 4967636
    [No Abstract]   [Full Text] [Related]  

  • 10. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial damage and hypofibrinolysis in systemic lupus erythematosus.
    Angles-Cano E
    Thromb Haemost; 1989 Apr; 61(2):322. PubMed ID: 2749604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravascular blood coagulation and immune complex inflammation in patients with systemic lupus erythematosus].
    Nasonova VA; Saĭkovskaia TV
    Ter Arkh; 1985; 57(7):91-8. PubMed ID: 2931851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of fibrinopeptide A in the control of systemic lupus erythematosus].
    Font J; Casals A; Bové A; Guerrero A; Ingelmo M; Balcells A
    Rev Clin Esp; 1986 Mar; 178(4):203-4. PubMed ID: 3715128
    [No Abstract]   [Full Text] [Related]  

  • 15. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
    Raleigh-Rosendo R; Diez-Ewald M; Vizcaíno G; Fereira H; Arteaga-Vizcaíno M; Arreaza M
    Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoglobulins and rheumatoid factor in systemic lupus erythematosus.
    Mustakallio KK; Lassus A; Putkonen T; Wager O
    Acta Derm Venereol; 1967; 47(4):241-8. PubMed ID: 4166059
    [No Abstract]   [Full Text] [Related]  

  • 17. [An analysis of the lymphoid cell histones in patients with different forms of lupus erythematosus].
    Khamaganova IV; Savina MI; Khromova SS; Reshina VM; Aleĭnikova NV
    Ter Arkh; 1996; 68(12):82-4. PubMed ID: 9054053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of fibrin in skin diseases. I. Lichen ruber planus and lupus erythematosus.
    Salo OP; Tallberg T; Mustakallio KK
    Acta Derm Venereol; 1972; 52(4):291-4. PubMed ID: 4115882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood serum glycosaminoglycans in assessing the degree of activity in systemic lupus erythematosus].
    Piriev BA; Ivanova MM; Kaĭnova AS; Astakhova TA
    Revmatologiia (Mosk); 1988; (2):29-34. PubMed ID: 3051273
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of association between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Mok CC; Lau CS
    J Rheumatol; 1996 Dec; 23(12):2185-6. PubMed ID: 8970067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.